CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer

Current Genomics · Published 2024-10-08 · DOI 10.2174/0113892029313473240919105819

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0113892029313473240919105819

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2024

Related articles